Page last updated: 2024-10-27

flumazenil and Metabolic Diseases

flumazenil has been researched along with Metabolic Diseases in 1 studies

Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.

Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sándor, J1
Nagy, A1
Földvári, A1
Szabó, E1
Csenteri, O1
Vincze, F1
Sipos, V1
Kovács, N1
Pálinkás, A1
Papp, M1
Fürjes, G1
Ádány, R1

Other Studies

1 other study available for flumazenil and Metabolic Diseases

ArticleYear
Delivery of cardio-metabolic preventive services to Hungarian Roma of different socio-economic strata.
    Family practice, 2017, Volume: 34, Issue:1

    Topics: Adult; Alcoholism; Blood Glucose; Cholesterol; Cross-Sectional Studies; Delivery of Health Care; Edu

2017